Medicine reimbursement recommendations in Canada, Australia, and Scotland.

This study was undertaken to compare the recommendations made by the Canadian Common Drug Review (CDR) regarding whether drugs should be listed on provincial and federal formularies with recommendations made by similar bodies in other countries.Retrospective cohort analysis.All recommendations made by CDR until September 30, 2006, were accessed. Two comparable agencies, the Australian Pharmaceutical Benefits Advisory Committee (PBAC) and the...